Literature DB >> 8384791

Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats.

C E Torgan1, J T Brozinick, E A Banks, M Y Cortez, R E Wilcox, J L Ivy.   

Abstract

This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats. Obese rats were randomly assigned to training, clenbuterol, or sedentary control groups. Lean littermates served as a second control group. After 4-5 wk of treatment, an oral glucose tolerance test was performed, followed 1 wk later by hindlimb perfusion, during which time the rates of glucose uptake and 3-O-methyl-D-glucose (3-MG) transport were assessed in the presence of a submaximal (500 microU/ml) insulin concentration. Training resulted in a significant increase in citrate synthase and cytochrome oxidase activity in the recruited muscles. Clenbuterol induced a large increase in muscle mass but provoked a significant decrease in oxidative enzyme activity and beta-adrenergic receptor density. Both treatments increased glucose tolerance and reduced the postglucose insulin response, with the improvements being more pronounced in the clenbuterol group. However, only exercise training improved insulin-stimulated hindlimb muscle glucose uptake (11.37 +/- 0.65, 8.73 +/- 0.77, and 8.27 +/- 0.41 mumol.g-1.h-1 for trained, clenbuterol, and sedentary control groups, respectively) and 3-MG transport. These results suggest that aerobic exercise training attenuated the insulin-resistant condition in the obese Zucker rat by a mechanism other than or in addition to beta 2-adrenergic receptor activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384791     DOI: 10.1152/ajpendo.1993.264.3.E373

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.

Authors:  Andrea L Hevener; Deborah J Clegg; Franck Mauvais-Jarvis
Journal:  Mol Cell Endocrinol       Date:  2015-05-29       Impact factor: 4.102

2.  Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats.

Authors:  Q Zhou; P L Dolan; G L Dohm
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 3.  Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.

Authors:  J L Ivy
Journal:  Sports Med       Date:  1997-11       Impact factor: 11.136

Review 4.  Muscle plasticity and β₂-adrenergic receptors: adaptive responses of β₂-adrenergic receptor expression to muscle hypertrophy and atrophy.

Authors:  Shogo Sato; Ken Shirato; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Biomed Biotechnol       Date:  2011-11-15

5.  Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.

Authors:  Anastasia Kalinovich; Nodi Dehvari; Alice Åslund; Sten van Beek; Carina Halleskog; Jessica Olsen; Elisabete Forsberg; Evelyn Zacharewicz; Gert Schaart; Mia Rinde; Anna Sandström; Roger Berlin; Claes-Göran Östenson; Joris Hoeks; Tore Bengtsson
Journal:  Diabetologia       Date:  2020-05-29       Impact factor: 10.122

6.  Effects of clenbuterol administration on mitochondrial morphology and its regulatory proteins in rat skeletal muscle.

Authors:  Yu Kitaoka; Daiki Watanabe; Yudai Nonaka; Kazuyoshi Yagishita; Yutaka Kano; Daisuke Hoshino
Journal:  Physiol Rep       Date:  2019-10

7.  Muscle hypertrophic effect of inhaled beta2 -agonist is associated with augmented insulin-stimulated whole-body glucose disposal in young men.

Authors:  Søren Jessen; Thomas Baasch-Skytte; Johan Onslev; Kasper Eibye; Vibeke Backer; Jens Bangsbo; Morten Hostrup
Journal:  J Physiol       Date:  2022-03-16       Impact factor: 6.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.